Skip to Main Content

Paper Details

Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy.
Clin Genitourin Cancer
4
2021
Author NameAffiliation
Jonathan D TwardHuntsman Cancer Institute, University of Utah
Thorsten SchlommCharite Universitatsmedizin
Stephen J FreedlandCedars-Sinai Medical Center, CA Durham VA Medical Center
  • 1 - 3

Datasets

Release 1.2